title: A Review of The Utility Values Used in Published Cost-Effectiveness Analyses of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy in Patients With Diabetic Nephropathy.
authors.affiliation: Eli Lilly and Company, Inc., Indianapolis, IN, USA.
authors.forename: R
authors.initials: R
authors.lastname: Paczkowski
authors.affiliation: Kennedy Martin Health Outcomes, East Sussex, UK.
authors.forename: T
authors.initials: T
authors.lastname: Kennedy-Martin
authors.affiliation: Kennedy Martin Health Outcomes, East Sussex, UK.
authors.forename: S
authors.initials: S
authors.lastname: Rayner